1. Gazzard , BG Moyle , GJ on behalf of the BHIVA Guideline Writing Committee. revision to the British HIV Association Guidelines for antiretroviral treatment of HIV seropositive individuals Lancet 1998
2. Carpenter , CJ Fischl , MA Hammer , SM et al. Antiretroviral therapy for HIV infection in JAMA 1998 280 78 86
3. Bertz , R Lam , W Brun , S Multiple dose pharmacokinetics of ABT-378/ritonavir (ABT-378/r) in HIV+ subjects. 39th Interscience Conference on Antimicrobial Agents and Chemotherapy
4. Saag , MS Kilby , M Ehrensing , E et al. Saquinavir systemic exposure and safety of once daily administration of Fortovase (saquinavir) soft gel capsule (FTV) in combination with low dose ritonavir 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. September, 1999
5. Kilby , M Hill , A Buss , N The effect of ritonavir on increases in saquinavir plasma concentration is independent of ritonavir dosage: combined analysis of 120 subjects 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. September, 2000